ADIPOSITY

Clinical trials for ADIPOSITY explained in plain language.

Never miss a new study

Get alerted when new ADIPOSITY trials appear

Sign up with your email to follow new studies for ADIPOSITY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 6 Not yet recruiting 1 Not yet finished but already full! 5 Completed 4

Weight-Loss drug may curb alcohol cravings in fatty liver patients

Disease control Not yet recruiting

This study tests whether semaglutide (a GLP-1 drug used for diabetes and weight loss) can help people with obesity and fatty liver disease stop drinking alcohol. About 64 participants will receive either semaglutide or a placebo, plus counseling, for 16 weeks. The main goal is to…

Matched conditions: ADIPOSITY

Phase: NA • Sponsor: Insel Gruppe AG, University Hospital Bern • Aim: Disease control

Last updated May 08, 2026 12:04 UTC

ADIPOSITY

Get alerted when new ADIPOSITY trials appear

Weight-Loss drug may curb alcohol cravings in fatty liver patients